acc43401 |
Glucose-6-phosphate 1-dehydrogenase |
oxidation |
Met125 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43402 |
Glucose-6-phosphate 1-dehydrogenase |
oxidation |
Met159 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43403 |
"C-1-tetrahydrofolate synthase, cytoplasmic" |
oxidation |
Met747 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Negative |
3.0 |
PXD051376
|
acc43404 |
"C-1-tetrahydrofolate synthase, cytoplasmic" |
oxidation |
Met304 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43405 |
X-ray repair cross-complementing protein 5 |
oxidation |
Met731 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43406 |
Gamma-interferon-inducible lysosomal thiol reductase |
oxidation |
Met185 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Negative |
3.0 |
PXD051376
|
acc43407 |
Elongation factor 2 |
oxidation |
Met383 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43408 |
Elongation factor 2 |
oxidation |
Met697 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43409 |
Protein disulfide-isomerase A4 |
oxidation |
Met488 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43410 |
Translationally-controlled tumor protein |
oxidation |
Met13 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43411 |
Translationally-controlled tumor protein |
oxidation |
Met115 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43412 |
TPT1-like protein |
oxidation |
Met120 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43413 |
Pyruvate kinase PKM |
oxidation |
Met360 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43414 |
Pyruvate kinase PKM |
oxidation |
Met334 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43415 |
Pyruvate kinase PKM |
oxidation |
Met22 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43416 |
Heterogeneous nuclear ribonucleoprotein L |
oxidation |
Met460 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Negative |
3.0 |
PXD051376
|
acc43417 |
Heterogeneous nuclear ribonucleoprotein L |
oxidation |
Met423 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43418 |
Junction plakoglobin |
oxidation |
Met89 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Negative |
3.0 |
PXD051376
|
acc43419 |
Ezrin |
oxidation |
Met200 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43420 |
Nucleoside diphosphate kinase A |
oxidation |
Met76 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43421 |
NAD(P)H dehydrogenase [quinone] 1 |
oxidation |
Met45 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43422 |
Desmoplakin |
oxidation |
Met2354 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Negative |
3.0 |
PXD051376
|
acc43423 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 |
oxidation |
Met220 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Negative |
3.0 |
PXD051376
|
acc43424 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 |
oxidation |
Met699 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Negative |
3.0 |
PXD051376
|
acc43425 |
"ATP-dependent 6-phosphofructokinase, liver type" |
oxidation |
Met30 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43426 |
"ATP-dependent 6-phosphofructokinase, platelet type" |
oxidation |
Met39 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43427 |
Galectin-3 |
oxidation |
Met130 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43428 |
T-complex protein 1 subunit alpha |
oxidation |
Met1 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43429 |
Ubiquitin-like modifier-activating enzyme 1 |
oxidation |
Met1015 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43430 |
Nucleoside diphosphate kinase B |
oxidation |
Met68 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43431 |
Putative nucleoside diphosphate kinase |
oxidation |
Met53 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43432 |
"Splicing factor, proline- and glutamine-rich" |
oxidation |
Met523 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43433 |
"Tryptophan--tRNA ligase, cytoplasmic" |
oxidation |
Met350 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43434 |
"Glycine cleavage system H protein, mitochondrial" |
oxidation |
Met147 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43435 |
Elongation factor 1-beta |
oxidation |
Met155 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43436 |
"ATP synthase subunit alpha, mitochondrial" |
oxidation |
Met479 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Negative |
3.0 |
PXD051376
|
acc43437 |
Polypyrimidine tract-binding protein 1 |
oxidation |
Met519 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Negative |
3.0 |
PXD051376
|
acc43438 |
Elongation factor 1-gamma |
oxidation |
Met263 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43439 |
Large ribosomal subunit protein uL16 |
oxidation |
Met184 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43440 |
Large ribosomal subunit protein uL16 |
oxidation |
Met52 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43441 |
Ephrin type-A receptor 2 |
oxidation |
Met688 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43442 |
Ephrin type-A receptor 2 |
oxidation |
Met689 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43443 |
Ephrin type-A receptor 2 |
oxidation |
Met695 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43444 |
Transketolase |
oxidation |
Met199 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43445 |
"Enoyl-CoA hydratase, mitochondrial" |
oxidation |
Met103 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43446 |
Heme oxygenase 2 |
oxidation |
Met113 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Negative |
3.0 |
PXD051376
|
acc43447 |
Bifunctional purine biosynthesis protein ATIC |
oxidation |
Met60 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43448 |
Bifunctional purine biosynthesis protein ATIC |
oxidation |
Met312 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43449 |
Heterogeneous nuclear ribonucleoprotein H3 |
oxidation |
Met290 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|
acc43450 |
Heterogeneous nuclear ribonucleoprotein H |
oxidation |
Met93 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 |
PXD051376
|